BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,862 | -15.8% | 37,074 | +5.9% | 0.00% | 0.0% |
Q2 2023 | $2,212 | +17.3% | 34,996 | -16.5% | 0.00% | 0.0% |
Q1 2023 | $1,886 | -18.1% | 41,925 | -20.3% | 0.00% | 0.0% |
Q4 2022 | $2,303 | -99.9% | 52,575 | +5.6% | 0.00% | -40.0% |
Q3 2022 | $3,280,000 | +45.4% | 49,779 | +11.5% | 0.01% | +66.7% |
Q2 2022 | $2,256,000 | -30.0% | 44,658 | -11.5% | 0.00% | 0.0% |
Q1 2022 | $3,225,000 | -37.8% | 50,478 | +4.2% | 0.00% | -40.0% |
Q4 2021 | $5,188,000 | +3.7% | 48,436 | -0.5% | 0.01% | 0.0% |
Q3 2021 | $5,003,000 | -1.8% | 48,662 | -16.0% | 0.01% | 0.0% |
Q2 2021 | $5,095,000 | -9.6% | 57,923 | -0.0% | 0.01% | -16.7% |
Q1 2021 | $5,634,000 | -13.3% | 57,950 | 0.0% | 0.01% | -14.3% |
Q4 2020 | $6,499,000 | +20.5% | 57,950 | -0.4% | 0.01% | 0.0% |
Q3 2020 | $5,395,000 | +20.7% | 58,200 | +1.6% | 0.01% | +16.7% |
Q2 2020 | $4,469,000 | +57.2% | 57,300 | +17.9% | 0.01% | +50.0% |
Q1 2020 | $2,842,000 | -19.2% | 48,600 | +10.7% | 0.00% | 0.0% |
Q4 2019 | $3,517,000 | -6.1% | 43,900 | -13.9% | 0.00% | -20.0% |
Q3 2019 | $3,747,000 | -26.9% | 51,000 | -6.1% | 0.01% | -16.7% |
Q2 2019 | $5,123,000 | +25.3% | 54,312 | +6.3% | 0.01% | +20.0% |
Q1 2019 | $4,089,000 | +86.8% | 51,077 | +25.8% | 0.01% | +66.7% |
Q4 2018 | $2,189,000 | -44.0% | 40,600 | -18.9% | 0.00% | -40.0% |
Q3 2018 | $3,910,000 | +23.0% | 50,086 | 0.0% | 0.01% | +25.0% |
Q2 2018 | $3,179,000 | -37.7% | 50,086 | -10.0% | 0.00% | -33.3% |
Q1 2018 | $5,103,000 | +32.6% | 55,649 | +9.0% | 0.01% | +20.0% |
Q4 2017 | $3,848,000 | +13.9% | 51,034 | +5.2% | 0.01% | +25.0% |
Q3 2017 | $3,379,000 | +49.2% | 48,507 | +8.6% | 0.00% | +33.3% |
Q2 2017 | $2,264,000 | +153.0% | 44,672 | +99.6% | 0.00% | +200.0% |
Q1 2017 | $895,000 | +55.7% | 22,383 | +9.2% | 0.00% | 0.0% |
Q4 2016 | $575,000 | -5.6% | 20,500 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $609,000 | +46.7% | 20,500 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $415,000 | +123.1% | 20,500 | +99.0% | 0.00% | – |
Q1 2016 | $186,000 | -31.4% | 10,300 | 0.0% | 0.00% | – |
Q4 2015 | $271,000 | +23.2% | 10,300 | 0.0% | 0.00% | – |
Q3 2015 | $220,000 | +36.6% | 10,300 | +69.1% | 0.00% | – |
Q2 2015 | $161,000 | – | 6,091 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |